Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.33 - $7.45 $198,781 - $342,014
-45,908 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.84 - $13.61 $397 - $925
68 Added 0.15%
45,908 $298,000
Q4 2021

Feb 14, 2022

SELL
$12.52 - $19.02 $76,459 - $116,155
-6,107 Reduced 11.76%
45,840 $614,000
Q3 2021

Nov 12, 2021

BUY
$10.47 - $20.87 $18,950 - $37,774
1,810 Added 3.61%
51,947 $747,000
Q2 2021

Aug 16, 2021

BUY
$13.9 - $22.58 $696,904 - $1.13 Million
50,137 New
50,137 $1.07 Million

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $17.2M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.